What is the main business of New Gen?

The main business activity of New Gen focuses on general medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 20, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Toruńska 27, 62-563 Licheń Stary.

Who is on the management board?

The management board includes Piotr Paweł Brendota (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,500 (approx. $1,486).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $502, representing a decrease of 88.3% compared to 2024.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of $3,442. For comparison, in 2024 the loss was $1,340, meaning the company increased its loss by 156.3%.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $178 in 2025, representing 100% of all operating expenses.

New Gensp. z o.o.

General medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-01-20

Share capital

5,500.00 PLN

Activity description

New Gen operates a medical and wellness center offering blood cleansing, stem-cell therapy, sessions in a normobaric chamber, and a spa zone. The company sells NewGen Liver, NewGen Enzymes, and NewGen Joints supplements, intended to support the liver, digestion, and regeneration of joints and cartilage, respectively.

Registered address

ul. Toruńska 27, 62-563 Licheń Stary, Poland

Website

newgen.com.pl

Phone

Financials

Revenue history

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 70 days late).

202519/06/2026
202427/05/2025
202308/05/2024
202219/06/2023
202123/09/2022
202015/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 502.26MedianUSD 766.37kAverageUSD 2.40m

Net profit

This companyUSD -3.44kMedianUSD 38.88kAverageUSD 163.61k

Operating costs

This companyUSD 177.80MedianUSD 680.10kAverageUSD 2.18m

Assets

This companyUSD 180.44kMedianUSD 262.36kAverageUSD 1.56m

Industry

Offer

Medical services
Stem cell therapy
Blood purification
Normobaric chamber
Dietary supplements

Website technology

Website

WordPress
Elementor

Authorized Representatives

Iwona Anna Daremiak – Management Board Member

Piotr Paweł Brendota – President of the Management Board

Manner of representation

If one member of the management board has been appointed, that member has the right to represent the company independently. If a multi-member management board has been appointed, the company is represented by two members of the management board acting jointly or by a member of the management board acting jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Balanski sp. z o.o.	60	$810.37	54.5455%
Piotr Paweł Brendotaage 55	19	$256.62	17.2727%
Mirosław Krzysztof Ziółkowskiage 66	20	$270.12	18.1818%
Others	11	$148.57	10%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	New Gen Suplementysp. z o.o.	1,350.62 USD	100%
	New Gen Laboratoriumsp. z o.o.	688.82 USD	51%

Bank accounts

Registered as a VAT taxpayer on 2024-05-01.

PKO Bank Polski
63 1020 1042 0000 8602 0464 1769

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl
Diagnosferasp. z o.o.	$746.32	diagnosfera.pl
Herbaculumsp. z o.o.	$346.46	herbaculum.pl

Change history

Date	Event
2021-09-22	Share capital increase (5,000.00 PLN → 5,500.00 PLN)
2020-01-20	Entered in the register

FAQ

Last updated: 2026-06-19